41
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis

, , , , , , & show all
Pages 794-803 | Received 18 May 2012, Accepted 10 Aug 2012, Published online: 02 Jan 2014

REFERENCES

  • Ishigami A, Maruyama N. Importance of research on peptidy-larginine deiminase and citrullinated proteins in age-related dis-ease. Geriatr Gerontol Int. 2010;10[Suppl 1]:S53–8.
  • Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays. 2003;25:1106–18.
  • Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 1996;271:30709–16.
  • Watanabe K, Akiyama K, Hikichi K, Ohtsuka R, Okuyama A, Senshu T. Combined biochemical and immunochemical com-parison of peptidylarginine deiminases present in various tissues. Biochim Biophys Acta. 1988;966:375–83.
  • Ishigami A, Asaga H, Ohsawa T, Akiyama K, Maruyama N. Peptidylarginine deiminase type I, type II, type III and type IV are expressed in rat epidermis. Biomed Res Tokyo. 2001;22: 63–5.
  • Ishigami A, Ohsawa T, Asaga H, Akiyama K, Kuramoto M, Maruyama N. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. Arch Biochem Biophys. 2002;407:25–31.
  • De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekercldiove B, et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as patho-physiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthr Rheum. 2005; 52:2323–30.
  • Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Mechin MC, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthr Rheum. 2007;56: 3541–53.
  • Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res. 2005;80:120–8.
  • Jang B, Kim E, Choi JK, Jin JK, Kim JI, Ishigami A, et al. Accumulation of citrullinated proteins by up-regulated peptidy-larginine deiminase 2 in brains of scrapie-infected mice: a pos-sible role in pathogenesis. Am J Pathol. 2008;173:1129–42.
  • Jang B, Jin JK, Jeon YC, Cho H.T, Ishigami A, Choi KC, et al. Involvement of peptidylarginine deiminase-mediated post-trans-lational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2010;119:199–210.
  • Nicholas AP. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci Lett. 2011;495:26–9.
  • Moscarello MA, Mastronardi FG, Wood DD. The role of citrul-linated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res. 2007;32:251–6.
  • Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheu-matoid arthritis. Nat Genet. 2003;34:395–402.
  • Liu YL, Chiang YH, Liu GY, Hung HC. Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4). PLoS ONE. 2011;6:e21314.
  • Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Ya-mamoto K. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol. 2005;34: 212–5.
  • Zhao J, Zhao Y, He J, Jia R, Li Z. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis. J Rheumatol. 2008;35: 969–74.
  • Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Lan-dewe R, Odegard S, et al. Serum IgG antibodies to peptidylarg-inine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis. 2008;67: 414–7.
  • Serdaroglu M, Cakirbay H, Deger 0, Cengiz S, Kul S. The association of anti-CCP antibodies with disease activity in rheumatoid arthritis. Rheumatol Int. 2008;28:965–70.
  • Wagner E, Skoumal M, Bayer PM, Klaushofer K. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int. 2009;29: 1315–21.
  • Shimada N, Handa S, Uchida Y, Fukuda M, Maruyama N, Asaga H, et al. Developmental and age-related changes of peptidylarg-inine deiminase 2 in the mouse brain. J Neurosci Res. 2010;88: 798–806.
  • Guerrin M, Ishigami A, Mechin MC, Nachat R, Valmary S, Sebbag M, et al. cDNA cloning, gene organization and expres-sion analysis of human peptidylarginine deiminase type I. Bio-chem J. 2003;370:167–74.
  • Nakashima K, Hagiwara T, Ishigami A, Nagata S, Asaga H, Kuramoto M, et al. Molecular characterization of peptidylargi-nine deiminase in HL-60 cells induced by retinoic acid and lalpha,25-dihydroxyvitamin D(3). J Biol Chem. 1999;274: 27786–92.
  • Lowry OH, Rosebrough NJ, Fan AL, Randall RJ. Protein mea-surement with the phenol reagent. J Cell Biol. 1951;193:265–75.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: pro-cedure and some applications. Proc Natl Acad Sci USA. 1979; 76:4350–4.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 1988;31:315–24.
  • Kolfenbach JR, Deane KD, Derber LA, O'Donnell CI, Gilliland WR, Edison JD, et al. Autoimmunity to peptidyl arginine dei-minase type 4 precedes clinical onset of rheumatoid arthritis. Arthr Rheum. 2010;62: 2633–9.
  • Pollmann S, Stensland M, Halvorsen EH, Sollid LM, Kvien TK, Fleckenstein B, et al. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate. Rheumatol Int. 2012;32(5),1271–6.
  • Andrade F, Danah E, Gucek M, Cole RN, Rosen A, Zhu X. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthr Rheum. 2010;62:1630–40.
  • Asaga H, Nakashima K, Senshu T, Ishigami A, Yamada M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol. 2001;70: 46–51.
  • Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis. 2004;63:373–81.
  • Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford). 2005;44:40–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.